You are using an older browser version. Please use a supported version for the best MSN experience.

Ozempic to ramp up production driven by off-label demand

Ozempic, created to treat diabetes, has been in short supply for months, fueled by people using it for its weight loss side effect. Now the manufacturer says it's planning to expand capacity.
image beaconimage beaconimage beacon